Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
11 Patents
#116 in Menlo Park, CA
#6,556 in California
#27,594 in US
#51,930 in the World
Cytopharm, Inc.
Forward Citations = 170
17 inventors:
Menlo Park, CA, United States of America
Cytopharm, Inc.
Calculating rank
Forward Citations = 170
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Emanuel Vogel (10 out of 10 patents)
Alexander D Cross (9 out of 9 patents)
Thomas Benninghaus (3 out of 3 patents)
4. Clemens Richert (3 out of 3 patents)
5. Martin Muller (3 out of 3 patents)
6. Giulio Jori (2 out of 7 patents)
7. Matthias Kocher (2 out of 4 patents)
8. Martin Mueller (2 out of 2 patents)
9. Otto Halpern (2 out of 2 patents)
10. Giulio Jori (1 out of 9 patents)
11. Norbert Jux (1 out of 1 patent)
12. Wolfgang Hennig (1 out of 1 patent)
13. Eduardo Rodriguez-Val (1 out of 1 patent)
14. Stefan Boehm (1 out of 1 patent)
15. Afssaneh Rahbar (1 out of 1 patent)
11 patents:
Company Overview
Cytopharm, Inc. is a biotechnology company based in Menlo Park, California, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing cellular and molecular therapies, particularly in the fields of immunology and regenerative medicine. With a commitment to harnessing the potential of biological systems, Cytopharm aims to address unmet medical needs through cutting-edge research and development, contributing to the evolution of healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytopharm, Inc.. Retrieved from https://idiyas.com/company/cytopharm
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]